http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. The American Society of Clinical Oncology (ASCO) has just released its annual report on the top cancer advances of the year. Clinical Cancer Advances 2012: ASCO's Annual Report on Progress Against Cancer, highlights major achievements in precision medicine, cancer screening and overcoming treatment resistance. http://medicalxpress.com/news/2012-12-american-society-clinical-oncology-issues.html Cancer Mon, 03 Dec 2012 16:00:12 EST news273757673 Modern contact lens materials are prone to drying when exposed to air, which contributes to the buildup of deposits on contact lenses, according to a study – "The Impact of Intermittent Air Exposure on Lipid Deposition", appearing in the November issue of Optometry and Vision Science, official journal of the American Academy of Optometry. http://medicalxpress.com/news/2012-11-air-exposure-affects-deposits-contact.html Ophthalmology Mon, 05 Nov 2012 16:30:29 EST news271355289 Experts are calling for an urgent change to approaches for treating and researching childhood cancers, to continue to save more children from the disease. http://medicalxpress.com/news/2012-10-treatment-alliance-children-cancer.html Cancer Mon, 08 Oct 2012 08:43:19 EST news268904593 A lysophosphatidic acid receptor 1 (LPAR1) inhibitor, known as Debio-0719, suppresses the development of metastases in mice by inducing cancer cell dormancy, according to a study published August 21 in the Journal of the National Cancer Institute. http://medicalxpress.com/news/2012-08-lpa1-inhibition-metastatic-dormancy-mouse.html Cancer Tue, 21 Aug 2012 16:00:07 EST news264782231 The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare. http://medicalxpress.com/news/2012-04-pancreatic-cancer-clinical-trial-results.html Cancer Tue, 03 Apr 2012 09:51:24 EST news252665467 After years studying the molecular bases of glioblastoma - the most common brain tumor and one of the most aggressive of all cancers, the group led by Dr. Joan Seoane , Director of Translational Research at the Vall d'Hebron Institute of Oncology (VHIO) and ICREA Research Professor has today published a study in Nature Medicine identifying USP15 as a critical protein in cancer which, thanks to its molecular characteristics, shows enormous therapeutic promise. http://medicalxpress.com/news/2012-02-usp15-biological-thermostat-therapeutic-cancer.html Cancer Sun, 19 Feb 2012 13:00:09 EST news248869719 There is a need to analyze tumor specimens at the time of ovarian cancer recurrence, according to a new study published in Molecular Cancer Therapeutics. Researchers used a diagnostic technology called molecular profiling to examine the differences in the molecular characteristics of primary and recurrent ovarian tumors and found significant changes for some biomarkers. This is the first study that examined potential differences in a broad biomarker panel in patient-matched primary versus recurrent ovarian cancers and underscores the importance of analyzing the most current tumor tissue in order to make the most informed decisions about treatment for recurrence. http://medicalxpress.com/news/2012-02-molecular-profiling-reveals-differences-primary.html Cancer Fri, 10 Feb 2012 13:06:25 EST news248101576 Researchers at the Stanford University School of Medicine have used an innovative mathematical technique to find markers that effectively predict how deadly a cancer will be. The discovery, which in this case concerned bladder cancer, could lead to faster, less expensive and more accurate analysis of cancer risk and better treatment of the disease. http://medicalxpress.com/news/2012-01-algorithm-bladder-cancer-marker.html Cancer Tue, 17 Jan 2012 09:06:30 EST news246013580 Whether chemotherapy is given before or after breast-conserving therapy (BCT) does not have an impact on long-term local-regional outcomes, suggesting treatment success is due more to biologic factors than chemotherapy timing, according to a study by researchers at The University of Texas MD Anderson Cancer Center. http://medicalxpress.com/news/2011-09-chemotherapy-effective-breast-cancer-surgery.html Cancer Thu, 08 Sep 2011 15:15:25 EST news234713696